AbCellera: A Platform To Pipeline Transition

AbCellera (NASDAQ: ABCL ) is a market leader for antibody discovery. Building out an integrated platform for antibody discovery and development. Their platform aims to generate best-in-class antibody medicines. The company validated its technology with over 100Analyst’s Disclosure: I/we have a beneficial long position in the shares of ABCL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (othe ...